These new models represent well-known CRPC phenotypes, including AR-driven (AR+) adenocarcinoma and AR-independent neuroendocrine-positive (NE+) or double-negative (AR–NE–) lineages (14, 17, 29, 30). Here, AR is linked to adenocarcinoma.